{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,4]],"date-time":"2022-04-04T10:09:36Z","timestamp":1649066976681},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Hautarzt"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1007\/s00105-013-2576-3","type":"journal-article","created":{"date-parts":[[2013,10,31]],"date-time":"2013-10-31T08:32:14Z","timestamp":1383208334000},"page":"806-809","source":"Crossref","is-referenced-by-count":0,"title":["Alopecia areata"],"prefix":"10.1007","volume":"64","author":[{"given":"V.","family":"von Felbert","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.F.","family":"Merk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,11,1]]},"reference":[{"key":"2576_CR1","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/j.1529-8019.2011.01419.x","volume":"24","author":"Alkhalifah","year":"2011","unstructured":"Alkhalifah A (2011) Topical and intralesional therapies for alopecia areata. Dermatol Ther 24:355\u2013363","journal-title":"Dermatol Ther"},{"key":"2576_CR2","doi-asserted-by":"crossref","first-page":"477","DOI":"10.4049\/jimmunol.1100657","volume":"188","author":"Alli","year":"2012","unstructured":"Alli R, Nguyen P, Boyd K et al (2012) A mouse model of clonal CD8+ T lymphocyte-mediated alopecia areata progressing to alopecia universalis. J Immunol 188:477\u2013486","journal-title":"J Immunol"},{"key":"2576_CR3","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.jaad.2009.04.031","volume":"61","author":"Barahmani","year":"2009","unstructured":"Barahmani N, Schabath MB, Duvic M (2009) History of atopyb or autoimmunity increases risk of alopecia areata. J Am Acad Dermatol 61:581\u2013591","journal-title":"J Am Acad Dermatol"},{"key":"2576_CR4","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1007\/s00105-003-0560-z","volume":"54","author":"Freyschmidt-Paul","year":"2003","unstructured":"Freyschmidt-Paul P, Happle R, Hoffmann R (2003) Alopecia areata. Hautarzt 54:713\u2013722","journal-title":"Hautarzt"},{"key":"2576_CR5","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1056\/NEJMra1103442","volume":"366","author":"Gilhar","year":"2012","unstructured":"Gilhar A, Etzioni A, Paus R (2012) Alopecia areata. N Engl J Med 366:1515\u20131525","journal-title":"N Engl J Med"},{"key":"2576_CR6","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1046\/j.0022-202x.2001.01583.x","volume":"117","author":"Gilhar","year":"2001","unstructured":"Gilhar A, Landau M, Assy B et al (2001) Melanocyte-associated T cell epitopes can function as autoantigens for transfer of alopecia areata to human scalp explants on Prkdcscid mice. J Invest Dermatol 117:1357\u20131362","journal-title":"J Invest Dermatol"},{"key":"2576_CR7","doi-asserted-by":"crossref","unstructured":"Hordinsky Maria K (2011) Treatment of alopecia areata: \u201eWhat is new on the horizon?\u201c Dermatol Ther 24:364\u2013368","DOI":"10.1111\/j.1529-8019.2011.01421.x"},{"key":"2576_CR8","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1001\/jamadermatol.2013.3049","volume":"149","author":"Huang","year":"2013","unstructured":"Huang KP, Mullangi S, Guo Y, Qureshi AA (2013) Autoimmune, atopic, and mental health comorbid conditions associated with alopecia areata in the United States. JAMA Dermatol 149(7):789\u2013794","journal-title":"JAMA Dermatol"},{"key":"2576_CR9","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.det.2012.08.014","volume":"31","author":"Jabbari","year":"2013","unstructured":"Jabbari A, Petukhova L, Cabral RM et al (2013) Genetic basis of alopecia areata: a roadmap for translational research. Dermatol Clin 31:109\u2013117","journal-title":"Dermatol Clin"},{"key":"2576_CR10","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1038\/jid.2010.427","volume":"131","author":"John","year":"2011","unstructured":"John KKG, Brockschmidt FF, Redler S et al (2011) Genetic variants in CTLA4 are strongly associated with alopecia areata. J Invest Dermatol 131:1169\u20131172","journal-title":"J Invest Dermatol"},{"key":"2576_CR11","doi-asserted-by":"crossref","first-page":"61","DOI":"10.5021\/ad.2012.24.1.61","volume":"24","author":"Lew","year":"2012","unstructured":"Lew BL, Cho HR, Haw S et al (2012) Association between IL17A\/IL17RA gene polymorphisms and susceptibility to alopecia areata in the korean population. Ann Dermatol 24(1):61\u201365","journal-title":"Ann Dermatol"},{"key":"2576_CR12","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1086\/511442","volume":"80","author":"Martinez-Mir","year":"2007","unstructured":"Martinez-Mir A, Zlotogorski A, Gordon D et al (2007) Genomewide scan for linkage reveals evidence of several susceptibility loci for alopecia areata. Am J Hum Genet 80:316\u2013328","journal-title":"Am J Hum Genet"},{"key":"2576_CR13","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1111\/j.1365-2133.2012.10955.x","volume":"166","author":"Messenger","year":"2012","unstructured":"Messenger AG, McKillop J, Farrant P et al (2012) Britisch Association of Dermatologists\u2018 guidelines for the management of alopecia areata 2012. Br J Dermatol 166:916\u2013926","journal-title":"Br J Dermatol"},{"key":"2576_CR14","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/nrd1989","volume":"5","author":"Moreland","year":"2006","unstructured":"Moreland L, Bate G, Kirkpatrick P (2006) Abatacept. Nat Rev 5:185\u2013186","journal-title":"Nat Rev"},{"key":"2576_CR15","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.jaad.2003.09.032","volume":"51","author":"Olsen","year":"2004","unstructured":"Olsen EA, Hordinsky MK, Price VH et al (2004) Alopecia areata investigational assessment guidelines \u2013 Part II. J Am Acad Dermatol 51:440\u2013447","journal-title":"J Am Acad Dermatol"},{"key":"2576_CR16","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1111\/j.1529-8019.2011.01420.x","volume":"24","author":"Otberg","year":"2011","unstructured":"Otberg N (2011) Systemic treatment for alopecia areata. Dermatol Ther 24:320\u2013325","journal-title":"Dermatol Ther"},{"key":"2576_CR17","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1111\/j.1529-8019.2011.01411.x","volume":"24","author":"Petukhova","year":"2011","unstructured":"Petukhova L, Carbal RM, Mackay-Wiggan J et al (2011) The genetics of alopecia areata: what\u2019s new and how will it help our patients? Dermatol Ther 24:326\u2013336","journal-title":"Dermatol Ther"},{"key":"2576_CR18","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/nature09114","volume":"466","author":"Petukhova","year":"2010","unstructured":"Petukhova L, Duvic M, Hordinsky M et al (2010) Genome-wide association study in alopecia areata implicates both innate and adaptive immunity. Nature 466(7302):113\u2013117","journal-title":"Nature"},{"key":"2576_CR19","unstructured":"Simpson NB (1995) Alopecia areata. In: Rook AR, Dawber RPR (Hrsg), Bunse TM, Merk HF (Hrsg Deutsche Ausgabe) Haarkrankheiten. Blackwell, Berlin, S\u00a0330\u2013371"},{"key":"2576_CR20","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1111\/j.1600-0625.2008.00773.x","volume":"17","author":"Sun","year":"2008","unstructured":"Sun J, Silva KA, McElwee KJ et al (2008) The C3H\/HeJ mouse and DEBR rat models for alopecia areata: a review of preclinical drug screening approaches and results. Exp Dermatol 17:793\u2013805","journal-title":"Exp Dermatol"},{"key":"2576_CR21","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1038\/jid.2011.203","volume":"131","author":"Sundberg","year":"2011","unstructured":"Sundberg JP, McElwee KJ, Carroll JM, King LE (2011) Hypothesis testing: CTLA4 co-stimulatory pathways critical in the pathogenesis of human and mouse alopecia areata. J Invest Dermatol 131:2323\u20132324","journal-title":"J Invest Dermatol"},{"key":"2576_CR22","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1111\/1523-1747.ep12355013","volume":"5","author":"Tosti","year":"1986","unstructured":"Tosti A, Colombati S, De Padova MP et al (1986) Retinal pigment epithelium function in alopecia areata. Soc Invest Dermatol 5:553\u2013555","journal-title":"Soc Invest Dermatol"},{"key":"2576_CR23","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.jaad.2006.05.008","volume":"55","author":"Tosti","year":"2006","unstructured":"Tosti A, Bellavista S, Iorizzo M (2006) Alopecia areata: a long term follow-up study of 191 patients. J Am Acad Dermatol 55:438\u2013441","journal-title":"J Am Acad Dermatol"},{"key":"2576_CR24","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1001\/jamadermatol.2013.360","volume":"149","author":"Tosti","year":"2013","unstructured":"Tosti A (2013) Alopecia areata and comorbid conditions. JAMA Dermatol 149(7):794","journal-title":"JAMA Dermatol"},{"key":"2576_CR25","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1146\/annurev-pathol-011110-130318","volume":"8","author":"Weaver","year":"2013","unstructured":"Weaver CT, Elson CO, Fouser LA, Kolls JK (2013) The Th17 pathway and inflammatory diseases of the intestines, lungs, and skin. Annu Rev Pathol 8:477\u2013512","journal-title":"Annu Rev Pathol"},{"key":"2576_CR26","first-page":"1063","volume":"137","author":"Wiseman","year":"2001","unstructured":"Wiseman MC, Shapiro J, MacDonald N, Lui H (2001) Predictive model for immunotherapy of alopecia areata with diphencyprone. Arch Dermatol 137:1063\u20131068","journal-title":"Arch Dermatol"}],"container-title":["Der Hautarzt"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-013-2576-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00105-013-2576-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-013-2576-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,22]],"date-time":"2019-05-22T23:38:01Z","timestamp":1558568281000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00105-013-2576-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11]]},"references-count":26,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2013,11]]}},"alternative-id":["2576"],"URL":"https:\/\/doi.org\/10.1007\/s00105-013-2576-3","relation":{},"ISSN":["0017-8470","1432-1173"],"issn-type":[{"value":"0017-8470","type":"print"},{"value":"1432-1173","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,11]]}}}